MedTrace Logo

Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

NCT06951347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-09-22

No results posted yet for this study

Summary

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia.

It aims to answer:

* Does sodium supplementation lower the length of hospital stay in children with pneumonia?
* Does potassium supplementation lower the length of hospital stay in children with pneumonia?

Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay.

Participants will:

• Take one sachet of oral rehydration solution (ORS) every day for 3 days.

Conditions

  • Childhood Pneumonia

Interventions

DIETARY_SUPPLEMENT

Oral Rehydration Solution

one sachet every day for 3 days

Sponsors & Collaborators

  • General Organization for Teaching Hospitals and Institutes

    lead OTHER

Principal Investigators

  • Marwa Taha, MD · Mataria Teaching Hospital, General Organization for Teaching Hospitals and Institutes, Cairo, Egypt

  • Hoda Atef Abdelsattar Ibrahim, MD · Faculty of Medicine, Cairo University, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2025-06-01
Completion
2025-06-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06951347 on ClinicalTrials.gov